NASDAQ:UTHR

United Therapeutics SEC Filings & 10K Form

$184.22
-1.24 (-0.67 %)
(As of 07/29/2021 12:00 AM ET)
Add
Compare
Today's Range
$184.05
$188.64
50-Day Range
$170.47
$188.72
52-Week Range
$98.37
$212.62
Volume131,417 shs
Average Volume344,449 shs
Market Capitalization$8.25 billion
P/E Ratio20.36
Dividend YieldN/A
Beta0.49

United Therapeutics (NASDAQ:UTHR) SEC Filings

DateFilerForm TypeView
07/14/2021
5:15 AM
United Therapeutics (Filer)
Form PRE 14A
07/09/2021
3:51 PM
Giltner Richard (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/09/2021
3:50 PM
DWEK RAYMOND (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/09/2021
3:49 PM
CAUSEY CHRISTOPHER (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/09/2021
3:49 PM
Olian Judy D. (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/30/2021
3:32 PM
DWEK RAYMOND (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/29/2021
3:39 PM
Thompson Tommy G (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/29/2021
3:36 PM
PATUSKY CHRISTOPHER (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/29/2021
3:34 PM
DWEK RAYMOND (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/29/2021
3:33 PM
Olian Judy D. (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/28/2021
5:54 PM
KURZWEIL RAY (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/28/2021
5:17 PM
SULLIVAN LOUIS W (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/28/2021
5:14 PM
Klein Katherine J (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/23/2021
5:01 AM
United Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/21/2021
3:32 PM
MAHON PAUL A (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2021
3:38 PM
United Therapeutics (Filer)
Form DEFA14A
06/16/2021
5:00 AM
United Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/07/2021
5:01 AM
United Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/04/2021
3:32 PM
MAHON PAUL A (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2021
5:00 AM
United Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/01/2021
3:30 PM
United Therapeutics (Filer)
Form SD
Specialized Disclosure Report  
05/24/2021
3:33 PM
MAHON PAUL A (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/12/2021
3:34 PM
SULLIVAN LOUIS W (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/10/2021
3:32 PM
MAHON PAUL A (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/10/2021
3:31 PM
PATUSKY CHRISTOPHER (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/06/2021
3:40 PM
DWEK RAYMOND (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/05/2021
5:17 AM
United Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/05/2021
5:10 AM
United Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/29/2021
3:32 PM
DWEK RAYMOND (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/29/2021
3:30 PM
United Therapeutics (Filer)
Form DEFA14A
04/29/2021
5:07 AM
United Therapeutics (Filer)
Form DEFA14A
04/29/2021
5:06 AM
United Therapeutics (Filer)
Form DEF 14A
04/22/2021
3:31 PM
DWEK RAYMOND (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/19/2021
5:02 AM
United Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/16/2021
3:33 PM
MAHON PAUL A (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/16/2021
3:32 PM
Giltner Richard (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/15/2021
3:32 PM
DWEK RAYMOND (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/08/2021
4:26 PM
DWEK RAYMOND (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2021
8:35 AM
MAHON PAUL A (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2021
8:33 AM
Olian Judy D. (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/01/2021
5:03 AM
United Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/29/2021
3:31 PM
KURZWEIL RAY (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2021
3:32 PM
MAHON PAUL A (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2021
3:32 PM
Olian Judy D. (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/16/2021
6:02 PM
MAHON PAUL A (Reporting)
United Therapeutics (Issuer)
Form 4/A
03/16/2021
6:00 PM
EDGEMOND JAMES (Reporting)
United Therapeutics (Issuer)
Form 4/A
03/16/2021
5:56 PM
ROTHBLATT MARTINE A (Reporting)
United Therapeutics (Issuer)
Form 4/A
03/16/2021
5:50 PM
BENKOWITZ MICHAEL (Reporting)
United Therapeutics (Issuer)
Form 4/A
03/16/2021
3:37 PM
EDGEMOND JAMES (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/16/2021
3:36 PM
ROTHBLATT MARTINE A (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2021
3:35 PM
Thompson Tommy G (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2021
4:26 PM
MAHON PAUL A (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2021
5:02 AM
United Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/01/2021
3:30 PM
ROTHBLATT MARTINE A (Filed by)
United Therapeutics (Subject)
Form SC 13G/A
02/24/2021
5:09 AM
United Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/24/2021
5:07 AM
United Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/19/2021
3:33 PM
MAHON PAUL A (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2021
7:08 AM
Avoro Capital Advisors LLC (Filed by)
United Therapeutics (Subject)
Form SC 13G
02/11/2021
1:18 PM
RENAISSANCE TECHNOLOGIES LLC (Filed by)
United Therapeutics (Subject)
Form SC 13G/A
02/10/2021
5:01 AM
United Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/08/2021
9:35 AM
FMR LLC (Filed by)
United Therapeutics (Subject)
Form SC 13G/A
02/05/2021
5:05 AM
United Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/05/2021
5:04 AM
TransMedics Group, Inc. (Subject)
United Therapeutics (Filed by)
Form SC 13G/A
02/01/2021
7:23 AM
BlackRock Inc. (Filed by)
United Therapeutics (Subject)
Form SC 13G/A
01/28/2021
5:01 AM
United Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/22/2021
3:31 PM
MAHON PAUL A (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/22/2021
5:01 AM
United Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/19/2021
3:39 PM
CAUSEY CHRISTOPHER (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2021
4:01 PM
United Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/08/2021
3:39 PM
MAHON PAUL A (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2021
3:38 PM
CAUSEY CHRISTOPHER (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2021
3:36 PM
Giltner Richard (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2021
3:35 PM
Giltner Richard (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2021
3:31 PM
CAUSEY CHRISTOPHER (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2021
3:30 PM
CAUSEY CHRISTOPHER (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/28/2020
3:32 PM
CAUSEY CHRISTOPHER (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/28/2020
5:08 AM
United Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/09/2020
3:31 PM
PATUSKY CHRISTOPHER (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/09/2020
5:00 AM
United Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/04/2020
3:51 PM
MAHON PAUL A (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/02/2020
5:01 AM
United Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/12/2020
3:33 PM
DWEK RAYMOND (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/12/2020
3:31 PM
ROTHBLATT MARTINE A (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/06/2020
3:31 PM
MAHON PAUL A (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/05/2020
3:33 PM
Giltner Richard (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/03/2020
3:44 PM
DWEK RAYMOND (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/03/2020
3:43 PM
BENKOWITZ MICHAEL (Reporting)
United Therapeutics (Issuer)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/29/2020
3:32 PM
CAUSEY CHRISTOPHER (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/28/2020
5:21 AM
United Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/28/2020
5:12 AM
United Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/23/2020
3:32 PM
CAUSEY CHRISTOPHER (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/19/2020
3:33 PM
CAUSEY CHRISTOPHER (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/11/2020
7:02 AM
MAXWELL LINDA (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/11/2020
7:01 AM
MAXWELL LINDA (Reporting)
United Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
09/11/2020
5:01 AM
United Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/17/2020
5:02 AM
United Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/06/2020
5:13 PM
PATUSKY CHRISTOPHER (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/29/2020
6:02 AM
United Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
07/29/2020
5:26 AM
United Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/29/2020
5:17 AM
United Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
This page was last updated on 7/30/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.